No internet connection — showing the saved version of the page.
← to majors

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN II (Beneficial Owner of more than 10% of a Class of Security)

insider

In companies of our database 1

CompanyStakeSharesReport date
Avalyn Pharma Inc.—1 275 4902026-05-01
advertisement